Patents by Inventor Thomas Reeves Parr

Thomas Reeves Parr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of oritavancin for prevention and treatment of anthrax
    Patent number: 9089507
    Abstract: Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against B. anthracis. Methods for the treatment, prophylaxis and prevention of B. anthracis infection and disease in animals, including humans, are described.
    Type: Grant
    Filed: September 24, 2007
    Date of Patent: July 28, 2015
    Assignee: THE MEDICINES COMPANY
    Inventors: Gregory Moeck, Thomas Reeves Parr, Jr.
  • USE OF ORITAVANCIN FOR PREVENTION AND TREATMENT OF ANTHRAX
    Publication number: 20100041585
    Abstract: Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against B. anthracis. Methods for the treatment, prophylaxis and prevention of B. anthracis infection and disease in animals, including humans, are described.
    Type: Application
    Filed: September 24, 2007
    Publication date: February 18, 2010
    Applicant: TARGANTA THERAPEUTICS CORP.
    Inventors: Gregory Moeck, Thomas Reeves Parr